BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23859518)

  • 1. Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.
    Rubió-Casadevall J; Borràs JL; Carmona-García MC; Ameijide A; Gonzalez-Vidal A; Ortiz MR; Bosch R; Riu F; Parada D; Martí E; Miró J; Sirvent JJ; Galceran J; Marcos-Gragera R
    World J Surg Oncol; 2015 Feb; 13():47. PubMed ID: 25885906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
    von Mehren M; Kane JM; Riedel RF; Sicklick JK; Pollack SM; Agulnik M; Bui MM; Carr-Ascher J; Choy E; Connelly M; Dry S; Ganjoo KN; Gonzalez RJ; Holder A; Homsi J; Keedy V; Kelly CM; Kim E; Liebner D; McCarter M; McGarry SV; Mesko NW; Meyer C; Pappo AS; Parkes AM; Petersen IA; Poppe M; Schuetze S; Shabason J; Spraker MB; Zimel M; Bergman MA; Sundar H; Hang LE
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1204-1214. PubMed ID: 36351335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors.
    Faucz FR; Horvath AD; Assié G; Almeida MQ; Szarek E; Boikos S; Angelousi A; Levy I; Maria AG; Chitnis A; Antonescu CR; Claus R; Bertherat J; Plass C; Eng C; Stratakis CA
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37578265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.
    Yoon H; Tang CM; Banerjee S; Yebra M; Noh S; Burgoyne AM; Torre J; Siena M; Liu M; Klug LR; Choi YY; Hosseini M; Delgado AL; Wang Z; French RP; Lowy A; DeMatteo RP; Heinrich MC; Molinolo AA; Gutkind JS; Harismendy O; Sicklick JK
    Oncogene; 2021 Mar; 40(11):1957-1973. PubMed ID: 33603171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in the GIST Field (Therapeutic Targets and Clinical Trial Staging).
    Huang C; Ma X; Wang M; Cao H
    Curr Drug Deliv; 2024; 21(1):80-90. PubMed ID: 36415101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-permeable PI3 kinase competitive peptide inhibits KIT mutant mediated tumorigenesis of gastrointestinal stromal tumor (GIST).
    Jiang Z; Guo Y; Shi J; Zhang S; Zhang L; Wang Y; Li G; Bai R; Zhao H; Sun J
    Mol Biol Rep; 2024 Jan; 51(1):98. PubMed ID: 38206538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Dose Sorafenib in Gastric Gastrointestinal Stromal Tumour with PDGFRA p.1843-D846 Deletion in an 88-Year-Old Male.
    Osmani AH
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):505-506. PubMed ID: 38576303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy Strategies for Gastrointestinal Stromal Tumor.
    Arshad J; Costa PA; Barreto-Coelho P; Valdes BN; Trent JC
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-KIT DNA aptamer-conjugated porous silicon nanoparticles for the targeted detection of gastrointestinal stromal tumors.
    Vijayakumar S; Nasr SH; Davis JE; Wang E; Zuidema JM; Lu YS; Lo YH; Sicklick JK; Sailor MJ; Ray P
    Nanoscale; 2022 Dec; 14(47):17700-17713. PubMed ID: 36416809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
    Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
    Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J; Miettinen M
    Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies].
    Emile JF
    Med Sci (Paris); 2013; 29(6-7):630-6. PubMed ID: 23859518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histology and molecular biology of GIST].
    Emile JF
    Bull Acad Natl Med; 2012; 196(4-5):835-44. PubMed ID: 23550446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.